RespiQ

Amsterdam, Netherlands Founded: 2019 • Age: 7 yrs
Digestive health is assessed via smart breath analysis devices.
Annual revenue - Latest available
Total funding $115,584 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors 4 Brand Intelligence

About RespiQ

RespiQ is a company based in Amsterdam (Netherlands) founded in 2019 by Mira Gleisberg. RespiQ has raised $115.58 thousand across 2 funding rounds from investors including EIC Fund and Antler. RespiQ offers products and services including Handheld Breathalyser and AI Analysis Algorithm. RespiQ operates in a competitive market with competitors including FoodMarble, Nutrifi and Erib Corp, among others.

  • Headquarter Amsterdam, Netherlands
  • Founders Mira Gleisberg
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Respiro B.V.
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $115.58 K (USD)

    in 2 rounds

  • Latest Funding Round
    $4.36 M (USD), Grant

    Nov 20, 2023

  • Investors
    EIC Fund

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of RespiQ

RespiQ offers a comprehensive portfolio of products and services, including Handheld Breathalyser and AI Analysis Algorithm.

Product name locked
Category locked
Primary

Device that detects breath biomarkers for early health issue identification.

Product name locked
Category locked
Locked

Software that processes breath data for personalized health insights.

People of RespiQ

Headcount 1-10
Employee Profiles 1
Board Members and Advisors 1
Employee Profiles
People
Mira Gleisberg
CEO & Co-founder

Unlock access to complete

Board Members and Advisors
people
Philip Siberg
Advisor

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of RespiQ

RespiQ has successfully raised a total of $115.58K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $4.36 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in RespiQ

RespiQ has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include EIC Fund and Antler.

All
Venture Fund
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Locked Locked Locked
Early-stage investing and founder support services are offered globally by Antler.
Locked Locked Locked
Premium access

Investor details for RespiQ

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by RespiQ

Investments
Premium access

Investment portfolio details for RespiQ

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - RespiQ

Premium access

Detailed financials for RespiQ

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Respiq Comparisons

RespiQ Primary company
Description
Digestive health is assessed via smart breath analysis devic...
Location
Amsterdam, Netherlands
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for RespiQ

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of RespiQ

RespiQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as FoodMarble, Nutrifi and Erib Corp, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Portable breath analyzer for digestive profile
Locked Locked Locked
Offers a platform for nutrition monitoring and management to support healthy lifestyles.
Locked Locked Locked
Develops wearable and swallowable sensors for stomach fluid analysis and diabetes management solutions.
Premium access

Detailed competitors of RespiQ

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Respiq

Premium access

Complete news archive for RespiQ

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about RespiQ

RespiQ was founded in 2019.

RespiQ is headquartered in Amsterdam, Netherlands.

RespiQ is a funded company, having raised a total of $115.58K across 2 funding rounds to date.

RespiQ was founded in 2019 in Amsterdam, Netherlands, and operates in the health technology sector. Smart devices are provided to analyze breath for biomarkers indicating undigested food types, aiding in the identification of dietary causes for digestive issues. A companion mobile app is offered, delivering dietary recommendations and health guidance to support user wellbeing. Operations focus on non-invasive monitoring tools for personal health management.

RespiQ's top competitors include FoodMarble, Nutrifi and Erib Corp.

RespiQ offers Handheld Breathalyser and AI Analysis Algorithm.

RespiQ has 2 investors. Key investors include EIC Fund, and Antler.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available